
Taylor V. Oh
Examiner (ID: 2006, Phone: (571)272-0689 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1621, 1623, 1625, 1622, 1711 |
| Total Applications | 2700 |
| Issued Applications | 1922 |
| Pending Applications | 233 |
| Abandoned Applications | 559 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17228543
[patent_doc_number] => 20210355099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => HIGHLY EFFICIENT SYNTHESIS OF Z-MACROCYCLES USING STEREORETENTIVE, RUTHENIUM-BASED METATHESIS CATALYSTS
[patent_app_type] => utility
[patent_app_number] => 17/336756
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336756 | Highly efficient synthesis of Z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts | Jun 1, 2021 | Issued |
Array
(
[id] => 17297773
[patent_doc_number] => 20210393612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => POLYMORPHIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/334094
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334094 | Polymorphic compounds and uses thereof | May 27, 2021 | Issued |
Array
(
[id] => 17356672
[patent_doc_number] => 20220017468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE
[patent_app_type] => utility
[patent_app_number] => 17/332805
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332805 | Isoquinoline compounds and their use in treating AhR imbalance | May 26, 2021 | Issued |
Array
(
[id] => 18405763
[patent_doc_number] => 20230167114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => MACROCYCLIC JAK INHIBITOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/999743
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999743 | MACROCYCLIC JAK INHIBITOR AND USE THEREOF | May 20, 2021 | Abandoned |
Array
(
[id] => 20849640
[patent_doc_number] => 12686664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => SOCE inhibitors and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/925738
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 11
[patent_no_of_words] => 25083
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925738 | SOCE Inhibitors and Therapeutic Uses Thereof | May 18, 2021 | Issued |
Array
(
[id] => 18492224
[patent_doc_number] => 11697634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Method and mixture to form functionalized cyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/322798
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14750
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322798 | Method and mixture to form functionalized cyclic compounds | May 16, 2021 | Issued |
Array
(
[id] => 18418443
[patent_doc_number] => 20230172901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/923782
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923782 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | May 6, 2021 | Abandoned |
Array
(
[id] => 18434269
[patent_doc_number] => 20230181563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => AKT3 MODULATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/923696
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923696 | AKT3 MODULATORS AND METHODS OF USE THEREOF | May 6, 2021 | Pending |
Array
(
[id] => 18932290
[patent_doc_number] => 11884697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Oxysterols and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/242860
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27274
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242860 | Oxysterols and methods of use thereof | Apr 27, 2021 | Issued |
Array
(
[id] => 18748337
[patent_doc_number] => 11807633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Chromene derivatives as inhibitors of TCR-Nck interaction
[patent_app_type] => utility
[patent_app_number] => 17/240041
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28307
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240041 | Chromene derivatives as inhibitors of TCR-Nck interaction | Apr 25, 2021 | Issued |
Array
(
[id] => 17022272
[patent_doc_number] => 20210246143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 17/239364
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239364 | Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators | Apr 22, 2021 | Issued |
Array
(
[id] => 18794111
[patent_doc_number] => 11827867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
[patent_app_type] => utility
[patent_app_number] => 17/301792
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28200
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301792 | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents | Apr 13, 2021 | Issued |
Array
(
[id] => 18503541
[patent_doc_number] => 11701331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Toxic aldehyde related diseases and treatment
[patent_app_type] => utility
[patent_app_number] => 17/227568
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25592
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227568 | Toxic aldehyde related diseases and treatment | Apr 11, 2021 | Issued |
Array
(
[id] => 17618908
[patent_doc_number] => 11337934
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-24
[patent_title] => Compositions including a cannabinoid and protocatechuic acid
[patent_app_type] => utility
[patent_app_number] => 17/225584
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7536
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225584 | Compositions including a cannabinoid and protocatechuic acid | Apr 7, 2021 | Issued |
Array
(
[id] => 18581515
[patent_doc_number] => 20230263767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING INFLAMMATORY DISEASE CONTAINING ISOOKANIN OR SALT THEREOF AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/020120
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020120
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020120 | COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING INFLAMMATORY DISEASE CONTAINING ISOOKANIN OR SALT THEREOF AS ACTIVE INGREDIENT | Apr 4, 2021 | Issued |
Array
(
[id] => 19216186
[patent_doc_number] => 20240180890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => VACCINE ADJUVANT
[patent_app_type] => utility
[patent_app_number] => 18/283158
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283158
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283158 | VACCINE ADJUVANT | Mar 30, 2021 | Pending |
Array
(
[id] => 17342096
[patent_doc_number] => 20220008427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => 3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
[patent_app_type] => utility
[patent_app_number] => 17/216106
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216106 | 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus | Mar 28, 2021 | Issued |
Array
(
[id] => 17513650
[patent_doc_number] => 11292779
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-05
[patent_title] => Process for production of essentially pure D8-tetrahydrocannabinol from cannabidiol extracted from hemp
[patent_app_type] => utility
[patent_app_number] => 17/214229
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11431
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214229 | Process for production of essentially pure D8-tetrahydrocannabinol from cannabidiol extracted from hemp | Mar 25, 2021 | Issued |
Array
(
[id] => 17081963
[patent_doc_number] => 20210276969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CONTINUOUS METHOD FOR PREPARING CARBONATE ESTERS
[patent_app_type] => utility
[patent_app_number] => 17/209742
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209742 | Continuous method for preparing carbonate esters | Mar 22, 2021 | Issued |
Array
(
[id] => 18363813
[patent_doc_number] => 20230145404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => H2O2 WITHOUT DIBC FOR PO PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/911673
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911673 | H | Mar 21, 2021 | Issued |